These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3277374)

  • 1. Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver.
    Fraschini G; Charnsangavej C; Carrasco CH; Buzdar AU; Jabboury KW; Hortobagyi GN
    Am J Clin Oncol; 1988 Feb; 11(1):34-8. PubMed ID: 3277374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer.
    Fraschini G; Fleishman G; Charnsangavej C; Carrasco CH; Hortobagyi GN
    Cancer Treat Rep; 1987 Nov; 71(11):1001-5. PubMed ID: 3677109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin in combination with continuous infusion vinblastine for refractory breast cancer.
    Fraschini G; Holmes FA; Buzdar AU; Hug V; Hortobagyi GN
    Am J Clin Oncol; 1988 Aug; 11(4):448-50. PubMed ID: 3407623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous hepatic arterial infusion of cisplatin for metastatic breast cancer.
    Fraschini G; Fleishman G; Yap HY; Carrasco CH; Charnsangavej C; Patt YZ; Hortobagyi GN
    Cancer Treat Rep; 1987 Mar; 71(3):313-5. PubMed ID: 3815396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndrome of inappropriate antidiuretic hormone secretion associated with hepatic arterial infusion of vinblastine in three patients with breast cancer.
    Fraschini G; Recchia F; Holmes FA
    Tumori; 1987 Oct; 73(5):513-6. PubMed ID: 3686684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
    Hsu C; Yeh KH; Hong RL; Yang CH; Lin MT; Chen YC; Cheng AL
    J Formos Med Assoc; 1997 Mar; 96(3):185-8. PubMed ID: 9080756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver.
    Mavligit GM; Pollock RE; Evans HL; Wallace S
    Cancer; 1993 Jul; 72(2):375-80. PubMed ID: 8391377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy.
    Sharma RA; Decatris MP; Santhanam S; Roy R; Osman AE; Clarke CB; Khanna S; O'Byrne KJ
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):367-70. PubMed ID: 12879281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
    Melichar B; Voboril Z; Lojík M; Krajina A
    Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine.
    Mavligit GM; Zukwiski AA; Ellis LM; Chuang VP; Wallace S
    Cancer; 1995 Apr; 75(8):2083-8. PubMed ID: 7697597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
    Blumenreich MS; Woodcock TM; Gentile PS; Barnes GR; Jose B; Sherrill EJ; Richman SP; Epremian BE; Kubota TT; Allegra JC
    J Clin Oncol; 1987 Nov; 5(11):1725-30. PubMed ID: 2824706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma.
    McDermott DF; Mier JW; Lawrence DP; van den Brink MR; Clancy MA; Rubin KM; Atkins MB
    Clin Cancer Res; 2000 Jun; 6(6):2201-8. PubMed ID: 10873069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma.
    Fazio N; Orsi F; Grasso RF; Ferretti G; Medici M; Rocca A; Zampino G; Curigliano G; De Pas T; Colleoni M; Bonomo G; Marrocco E; Lunghi L; De Braud F
    Anticancer Res; 2003; 23(6D):5023-30. PubMed ID: 14981962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
    Legha SS; Ring S; Eton O; Bedikian A; Buzaid AC; Plager C; Papadopoulos N
    J Clin Oncol; 1998 May; 16(5):1752-9. PubMed ID: 9586888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement.
    Tsimberidou AM; Moulder S; Fu S; Wen S; Naing A; Bedikian AY; Daring S; Uehara C; Ng C; Wallace M; Camacho L; Kurzrock R
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1087-93. PubMed ID: 20204368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival.
    Patt YZ; Charnsangavej C; Yoffe B; Smith R; Lawrence D; Chuang V; Carrasco H; Roh M; Chase J; Fischer H
    J Clin Oncol; 1994 Jun; 12(6):1204-11. PubMed ID: 8201383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer.
    Yap HY; Blumenschein GR; Hortobagyi GN; Buzdar AU; Schell FC; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):511-4. PubMed ID: 7180829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.